Adding Peptide Therapy to Your Practice

Why Providers Are Adding Peptides

Peptide therapy is one of the fastest-growing segments in integrative and functional medicine. Patient demand is surging — driven by social media awareness, longevity research, and frustration with conventional approaches. Practices that offer peptide therapy report higher patient retention, increased revenue per visit, and a competitive edge in their market.

Getting Started: Legal & Regulatory

The regulatory landscape for peptide therapy varies by state and provider type. Understanding the requirements before you start is critical to protecting your practice.

• ✓Verify your state board allows prescribing compounded peptides under your license type
• ✓Establish relationships with 503A or 503B compounding pharmacies
• ✓Document clinical rationale for each peptide prescription in the patient chart
• ✓Stay current on FDA enforcement actions — the landscape is evolving rapidly
• ✓Consider joining professional organizations like A4M, IFM, or SSRP for continuing education

Building Your Protocol Library

Start with the highest-demand, best-evidence peptides and expand from there. Most practices launch with 3-5 core peptides before broadening their formulary.

• ✓BPC-157 — healing and recovery, broad application, strong safety profile
• ✓CJC-1295 + Ipamorelin — growth hormone optimization, anti-aging, body composition
• ✓Semaglutide / Tirzepatide — weight management, massive patient demand
• ✓PT-141 — sexual health, addresses a common unmet need
• ✓Thymosin Alpha-1 — immune optimization, post-illness recovery

Patient Selection & Safety

Not every patient is a candidate for peptide therapy. Proper screening includes comprehensive lab work, review of current medications for interactions, cancer history screening, and pregnancy status. Establish clear inclusion and exclusion criteria for your practice.

Using Technology for Clinical Efficiency

The biggest barrier to adding peptide therapy is the time required for protocol development, drug interaction checking, and patient education. AI-powered tools can dramatically reduce this burden — generating evidence-based protocols, checking interactions against current medications, and producing patient-ready handouts in minutes instead of hours.

Revenue Impact

Peptide therapy is typically cash-pay, making it high-margin for practices. Initial consultations, ongoing monitoring, and the peptides themselves create a recurring revenue model. Practices report an average increase of 30-50% in revenue per patient when adding peptide and optimization services.